Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes

作者: Nicholas J Leeper , Anna Bauer-Mehren , Srinivasan V Iyer , Paea LePendu , Cliff Olson

DOI: 10.1371/JOURNAL.PONE.0063499

关键词:

摘要: Background Peripheral arterial disease (PAD) is a growing problem with few available therapies. Cilostazol the only FDA-approved medication class I indication for intermittent claudication, but carries black box warning due to concerns increased cardiovascular mortality. To assess validity of this warning, we employed novel text-analytics pipeline quantify adverse events associated use in clinical setting, including patients congestive heart failure (CHF).

参考文章(38)
Nigam H. Shah, Mark A. Musen, Rong Xu, A Comprehensive Analysis of Five Million UMLS Metathesaurus Terms Using Eighteen Million MEDLINE Citations. american medical informatics association annual symposium. ,vol. 2010, pp. 907- 911 ,(2010)
Wendy W. Chapman, David Chu, John N. Dowling, ConText: An Algorithm for Identifying Contextual Features from Clinical Text meeting of the association for computational linguistics. pp. 81- 88 ,(2007) , 10.3115/1572392.1572408
Paea LePendu, Yi Liu, Srinivasan Iyer, Madeleine R Udell, Nigam H Shah, Analyzing patterns of drug use in clinical notes for patient safety. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science. ,vol. 2012, pp. 63- 70 ,(2012)
Clement Jonquet, Nigam H. Shah, Mark A. Musen, Rong Xu, Gautam K. Parai, The Lexicon Builder Web service: Building Custom Lexicons from two hundred Biomedical Ontologies. american medical informatics association annual symposium. ,vol. 2010, pp. 587- 591 ,(2010)
Paea LePendu, Nigam H. Shah, Srinivasan Iyer, Yi Liu, Using Temporal Patterns in Medical Records to Discern Adverse Drug Events from Indications AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science. ,vol. 2012, pp. 47- 56 ,(2012)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Yung-Wei Chi, Carl J Lavie, Richard V Milani, Christopher J White, Safety and efficacy of cilostazol in the management of intermittent claudication. Vascular Health and Risk Management. ,vol. 4, pp. 1197- 1203 ,(2008) , 10.2147/VHRM.S3160
L. Mechtouff, E. Touzé, P. G. Steg, E. M. Ohman, S. Goto, A. T. Hirsch, J. Röther, F. T. Aichner, C. Weimar, D. L. Bhatt, M. J. Alberts, J.-L. Mas, , Original Article: Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease Journal of Internal Medicine. ,vol. 267, pp. 621- 633 ,(2009) , 10.1111/J.1365-2796.2009.02198.X
Peter Robless, Dimitris P Mikhailidis, Gerard P Stansby, Cilostazol for peripheral arterial disease Cochrane Database of Systematic Reviews. ,(2008) , 10.1002/14651858.CD003748.PUB3
MITCHELL H. GAIL, JAY H. LUBIN, LAWRENCE V. RUBINSTEIN, Likelihood calculations for matched case-control studies and survival studies with tied death times Biometrika. ,vol. 68, pp. 703- 707 ,(1981) , 10.1093/BIOMET/68.3.703